MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-10-2026
Medpace Holdings Shares 2011-2026 | MEDP
Annual Shares Medpace Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28.8 M | 31 M | 30.7 M | 32.4 M | 35.9 M | 35.6 M | 35.9 M | 35.5 M | 39.1 M | 35.7 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 39.1 M | 28.8 M | 34.1 M |
Quarterly Shares Medpace Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28.1 M | 28.6 M | 30.4 M | 30.6 M | 31 M | 31 M | 30.8 M | 30.8 M | 30.6 M | 30.5 M | 31 M | 31.1 M | 31 M | 32.5 M | 34.9 M | 36 M | 35.8 M | 35.9 M | 35.8 M | 35.5 M | 35.6 M | 35.4 M | 36 M | 36.1 M | 35.9 M | 35.8 M | 35.7 M | 35.7 M | 35.6 M | 35.5 M | 35.5 M | 35.5 M | 38.6 M | 40.2 M | 40.7 M | 40.7 M | 37.1 M | 32.6 M | 32.6 M | 32.6 M | 31.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 40.7 M | 28.1 M | 34.1 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Agilent Technologies
A
|
304 M | $ 118.41 | -1.12 % | $ 36 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 19.13 | -6.98 % | $ 206 M |  China |
 |
Check-Cap Ltd.
CHEK
|
5.85 M | - | - | $ 9.42 M |  Israel |
 |
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
53.3 M | $ 20.4 | 16.11 % | $ 1.09 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | USA |
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
1.33 M | $ 1.44 | 1.24 % | $ 1.92 M | USA |
 |
Castle Biosciences
CSTL
|
27.8 M | $ 24.65 | 0.12 % | $ 685 M | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
49.6 M | $ 182.43 | 0.98 % | $ 9.04 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
Danaher Corporation
DHR
|
713 M | $ 194.63 | -1.75 % | $ 139 B | USA |
 |
Interpace Biosciences
IDXG
|
4.42 M | $ 2.2 | - | $ 9.73 M | USA |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
159 M | $ 129.72 | -1.92 % | $ 20.6 B | USA |
 |
Fulgent Genetics
FLGT
|
30.2 M | $ 16.11 | -0.34 % | $ 487 M | USA |
 |
Guardant Health
GH
|
125 M | $ 85.08 | 0.26 % | $ 10.7 B | USA |
 |
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B |  Niderland |
 |
NeoGenomics
NEO
|
128 M | $ 8.57 | -1.32 % | $ 1.1 B | USA |
 |
Anixa Biosciences
ANIX
|
32.5 K | $ 2.88 | -1.7 % | $ 93.5 K | USA |
 |
Biomerica
BMRA
|
2.3 M | $ 2.12 | 0.47 % | $ 4.87 M | USA |
 |
ICON Public Limited Company
ICLR
|
82.5 M | $ 116.64 | 0.12 % | $ 9.62 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 268.68 | 0.67 % | $ 22.4 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
904 M | $ 29.16 | 0.31 % | $ 20 B | Niderland |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | Israel |
 |
Celcuity
CELC
|
46.8 M | $ 123.38 | -0.08 % | $ 5.77 B | USA |
 |
Senseonics Holdings
SENS
|
41.7 M | $ 6.79 | -1.59 % | $ 283 M | USA |
 |
Myriad Genetics
MYGN
|
92.6 M | $ 5.12 | -1.35 % | $ 474 M | USA |
 |
Lantheus Holdings
LNTH
|
67.5 M | $ 84.11 | 0.2 % | $ 5.68 B | USA |
 |
Soleno Therapeutics
SLNO
|
50.8 M | $ 52.65 | 0.14 % | $ 2.68 B | USA |
 |
Neuronetics
STIM
|
66 M | $ 1.37 | -1.44 % | $ 90.4 M | USA |
 |
Neogen Corporation
NEOG
|
217 M | $ 9.36 | -0.64 % | $ 2.03 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 193.25 | 1.0 % | $ 21.5 B | USA |
 |
ENDRA Life Sciences
NDRA
|
787 K | $ 5.14 | - | $ 4.05 M | USA |
 |
Invitae Corporation
NVTA
|
236 M | - | - | $ 21.2 M | USA |
 |
National Research Corporation
NRC
|
22.4 M | $ 17.73 | -0.62 % | $ 397 M | USA |
 |
Thermo Fisher Scientific
TMO
|
377 M | $ 524.62 | -1.3 % | $ 198 B | USA |